Covestor LTD Ngm Biopharmaceuticals Inc Transaction History

Covestor LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.17 - $1.92 $3 - $5	-3 Reduced 4.62%	62 $0
Q4 2023 Feb 09, 2024	BUY	$0.6 - $1.31 $28 - $61	47 Added 261.11%	65 $0
Q3 2023 Nov 13, 2023	SELL	$1.05 - $3.37 $3 - $10	-3 Reduced 14.29%	18 $0
Q2 2023 Aug 11, 2023	SELL	$2.44 - $4.53 $2 - $4	-1 Reduced 4.55%	21 $0
Q1 2023 May 15, 2023	SELL	$3.72 - $5.4 $37 - $54	-10 Reduced 31.25%	22 $0
Q4 2022 Feb 13, 2023	BUY	$3.41 - $12.93 $64 - $245	19 Added 146.15%	32 $0
Q3 2022 Nov 14, 2022	SELL	$12.59 - $17.67 $25 - $35	-2 Reduced 13.33%	13 $0
Q2 2022 Aug 10, 2022	SELL	$10.58 - $17.5 $42 - $70	-4 Reduced 21.05%	15 $0
Q1 2022 May 13, 2022	BUY	$13.81 - $18.6 $13 - $18	1 Added 5.56%	19 $0
Q4 2021 Feb 10, 2022	BUY	$17.26 - $22.02 $310 - $396	18 New	18 $0

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.